• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载亚麻氰苷聚(D,L-丙交酯-共-乙交酯)纳米粒的体外降解。

In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.

机构信息

Department of Chemical and Environmental Engineering, Faculty of Engineering, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.

出版信息

IET Nanobiotechnol. 2013 Jun;7(2):33-41. doi: 10.1049/iet-nbt.2012.0012.

DOI:10.1049/iet-nbt.2012.0012
PMID:24046903
Abstract

Linamarin-loaded poly (lactide-co-glycolide) (PLGA) nanoparticles (NPs) were prepared by the double emulsion solvent evaporation technique. The formulated PLGA (50:50) and PLGA (85:15) NPs were spherically shaped, having an average particle size < 190 nm, drug entrapment efficiency (50-52%) and zeta potentials ranging from -25 to -30 mV. Interestingly, all formulated PLGA NPs exhibited a controlled biphasic release profile. Polymer degradation was investigated in the current research to determine the major degradation products and then the polymer biocompatibility as well as safety. The PLGA NPs degradation behaviour was investigated by measuring water uptake, mass loss, change of pH of the degradation medium, morphological changes, and lactic and glycolic acid concentrations. Gravimetrical methods, pH meter, scanning electron microscope and high-performance liquid chromatography were employed, respectively. PLGA (50:50) NPs were found to degrade faster than PLGA (85:15) NPs. With regard to water uptake, mass loss and pH change, the degradation behaviour of PLGA (50:50) NPs was significantly (rho < 0.05) different from that of PLGA (85:15) NPs. A complete degradation of PLGA (50:50) NPs was achieved after 102 days, whereas, only about 60% of PLGA (85:15) NPs were degraded within the same period. Complete degradation and release of the degradation products naturally by the body ensures safety of the delivery carrier.

摘要

用双乳液溶剂蒸发技术制备了负载黎豆氨酸的聚(乳酸-共-乙醇酸)(PLGA)纳米粒子(NPs)。所制备的 PLGA(50:50)和 PLGA(85:15)NPs 呈球形,平均粒径<190nm,药物包封效率(50-52%)和zeta 电位在-25 到-30mV 之间。有趣的是,所有的 PLGA NPs 均表现出一种控制的两相释放模式。在当前的研究中,对聚合物降解进行了研究,以确定主要的降解产物,然后评估聚合物的生物相容性和安全性。通过测量水摄取、质量损失、降解介质 pH 值的变化、形态变化以及乳酸和乙醇酸的浓度,研究了 PLGA NPs 的降解行为。分别采用重量法、pH 计、扫描电子显微镜和高效液相色谱法。PLGA(50:50)NPs 的降解速度明显快于 PLGA(85:15)NPs。就水摄取、质量损失和 pH 值变化而言,PLGA(50:50)NPs 的降解行为与 PLGA(85:15)NPs 有显著差异(rho < 0.05)。PLGA(50:50)NPs 在 102 天后完全降解,而在相同时间内,只有大约 60%的 PLGA(85:15)NPs 降解。PLGA(50:50)NPs 的完全降解和降解产物的自然释放可确保载体的安全性。

相似文献

1
In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.载亚麻氰苷聚(D,L-丙交酯-共-乙交酯)纳米粒的体外降解。
IET Nanobiotechnol. 2013 Jun;7(2):33-41. doi: 10.1049/iet-nbt.2012.0012.
2
Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).六臂星形聚(乳酸-共-乙醇酸)载紫杉醇的合成、表征及评价。
Int J Nanomedicine. 2013;8:4315-26. doi: 10.2147/IJN.S51629. Epub 2013 Nov 7.
3
Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.壳聚糖和壳寡糖表面修饰聚合物纳米粒用于黏膜给蛋白递药:提高黏膜黏附性和细胞摄取。
Drug Deliv Transl Res. 2016 Aug;6(4):365-79. doi: 10.1007/s13346-016-0295-x.
4
Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.载比卡鲁胺聚乳酸-羟基乙酸共聚物纳米粒的研制:制备、表征及前列腺癌治疗的体外评价
Artif Cells Nanomed Biotechnol. 2017 Aug;45(5):944-954. doi: 10.1080/21691401.2016.1196457. Epub 2016 Jun 21.
5
Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.用于靶向治疗肠道癌症的表面修饰 PLGA 聚合物纳米颗粒的制备与表征。
Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):432-446. doi: 10.1080/21691401.2017.1324466. Epub 2017 May 14.
6
Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.载 9-硝基喜树碱长循环纳米粒的制备及其在癌症患者体内的体外特性研究。
Int J Nanomedicine. 2010 Aug 9;5:463-71. doi: 10.2147/ijn.s11586.
7
[Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].阿霉素负载聚乳酸-羟基乙酸共聚物纳米粒的处方及工艺优化及其体外释放
Yao Xue Xue Bao. 2013 May;48(5):759-66.
8
Bromelain Loaded Lipid-Polymer Hybrid Nanoparticles for Oral Delivery: Formulation and Characterization.菠萝蛋白酶负载的脂质-聚合物杂化纳米粒用于口服给药:制剂与表征。
Appl Biochem Biotechnol. 2022 Aug;194(8):3733-3748. doi: 10.1007/s12010-022-03812-z. Epub 2022 May 4.
9
Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.原位合成金纳米粒子于壳聚糖功能化 PLGA 纳米粒用于口服胰岛素递药
Int J Biol Macromol. 2022 Jun 1;209(Pt B):2188-2196. doi: 10.1016/j.ijbiomac.2022.04.200. Epub 2022 May 2.
10
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.用于静脉注射的载多西他赛聚乳酸-羟基乙酸共聚物和聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒:药代动力学和生物分布特征
Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017.

引用本文的文献

1
Magnesium phosphate functionalized graphene oxide and PLGA composite matrices with enhanced mechanical and osteogenic properties for bone regeneration.具有增强力学性能和成骨性能的磷酸镁功能化氧化石墨烯与聚乳酸-羟基乙酸共聚物复合基质用于骨再生
Regen Biomater. 2025 Jul 26;12:rbaf074. doi: 10.1093/rb/rbaf074. eCollection 2025.
2
3D-Printed Poly (Lactic-Co-Glycolic Acid) and Graphene Oxide Nerve Guidance Conduit with Mesenchymal Stem Cells for Effective Axon Regeneration in a Rat Sciatic Nerve Defect Model.用于大鼠坐骨神经缺损模型中有效轴突再生的3D打印聚(乳酸-乙醇酸)与氧化石墨烯神经导管及间充质干细胞
Int J Nanomedicine. 2025 Mar 13;20:3201-3217. doi: 10.2147/IJN.S501241. eCollection 2025.
3
Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy.
调控中性粒细胞命运以调控炎症和修复治疗心肌梗死。
Nat Commun. 2024 Oct 1;15(1):8481. doi: 10.1038/s41467-024-52812-6.
4
Developing a synergistic rate-retarding polymeric implant for controlling monoclonal antibody delivery in minimally invasive glaucoma surgery.开发协同控释聚合物植入物以控制微创青光眼手术中单抗药物的释放。
Int J Biol Macromol. 2024 Jun;272(Pt 1):132655. doi: 10.1016/j.ijbiomac.2024.132655. Epub 2024 May 24.
5
Silane-modified hydroxyapatite nanoparticles incorporated into polydioxanone/poly(lactide--caprolactone) creates a novel toughened nanocomposite with improved material properties and inflammatory responses.硅烷改性羟基磷灰石纳米颗粒与聚二氧六环酮/聚(丙交酯-己内酯)复合,形成了一种新型的增韧纳米复合材料,其材料性能和炎症反应均得到改善。
Mater Today Bio. 2023 Aug 24;22:100778. doi: 10.1016/j.mtbio.2023.100778. eCollection 2023 Oct.
6
Nanoparticular and other carriers to deliver lactoferrin for antimicrobial, antibiofilm and bone-regenerating effects: a review.纳米颗粒和其他载体递送乳铁蛋白用于抗菌、抗生物膜和骨再生作用:综述。
Biometals. 2023 Jun;36(3):709-727. doi: 10.1007/s10534-022-00455-9. Epub 2022 Dec 13.
7
A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics.一种针对酸性肿瘤微环境的化疗方法:质子泵抑制剂与紫杉醇联合用于统计学优化的纳米治疗剂。
RSC Adv. 2019 Jan 2;9(1):240-254. doi: 10.1039/c8ra08924h. eCollection 2018 Dec 19.
8
Fabrication of subunit nanovaccines by physical interaction.通过物理相互作用制备亚单位纳米疫苗。
Sci China Technol Sci. 2022;65(5):989-999. doi: 10.1007/s11431-021-2011-7. Epub 2022 Apr 8.
9
Characterization of a Sandwich PLGA-Gallic Acid-PLGA Coating on Mg Alloy ZK60 for Bioresorbable Coronary Artery Stents.用于生物可吸收冠状动脉支架的镁合金ZK60上的夹心PLGA-没食子酸-PLGA涂层的表征
Materials (Basel). 2020 Dec 4;13(23):5538. doi: 10.3390/ma13235538.
10
Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles.应用统计设计评估聚合物纳米颗粒的关键工艺参数并优化其制剂技术。
R Soc Open Sci. 2019 Jul 24;6(7):190896. doi: 10.1098/rsos.190896. eCollection 2019 Jul.